Abstract Long-Acting Injectable Antipsychotics (LAIs) are used to overcome non-compliance
in psychoses, mainly schizophrenia spectrum disorders. We aimed to summarize available …

Background: Concurrent disorder or dual diagnosis refers to a combination of substance use
disorders and mental disorders that occur in the same patient simultaneously. These …

Objective: This study compared relapse prevention and acceptability of long-acting
injectable (LAI) antipsychotics in the maintenance treatment of adults with nonaffective …

Dopamine receptor partial agonists (DRPAs; aripiprazole, brexpiprazole, and cariprazine)
constitute a novel class of antipsychotics. Although they share a similar mechanism of …

Introduction Maintenance antipsychotic treatment improves multiple outcomes in people with
schizophrenia. These benefits are challenged by medication nonadherence, which is a …

Objectives: Co-occurring substance use disorders (SUDs) among individuals with
schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with …

Background Partial dopamine D2 receptor agonists are used for psychotic symptoms in
adults with schizophrenia spectrum disorders. Recently, interest surged for partial dopamine …

Treatment discontinuation is a major challenge in routine clinical settings. Despite poor
adherence to antipsychotic medication, long acting injectable (LAI) formulations are an …

Aim Substance use disorder (SUD) is highly prevalent among patients with first‐episode
psychosis (FEP) and associated with poor adherence and worst treatment outcomes …

Introduction Comorbidity of substance use disorder (SUD) with schizophrenia, referred to as
dual disorder (DD), significantly increases morbidity and mortality compared to …